The effect of the co-ingestion of probiotics and poly- and oligo-saccharides on gut microbiota
Not Applicable
Not yet recruiting
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000052935
- Lead Sponsor
- Yakult Central Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1. Subjects who are pregnant or possibly pregnant. 2. Subjects regularly taking laxatives or antibiotics 3. Subjects judged as unsuitable for the study participant 4. Subjects participating or willing to participate in other studies with food intervention 5. Subjects judged as unsuitable for the study participant by principal investigator from other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Abundance of the probiotics in fecal samples
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain the synergistic effect of probiotics and poly-oligo-saccharides on gut microbiota in healthy adults?
How does the combination of probiotics and poly-oligo-saccharides compare to standard prebiotic/probiotic therapies in modulating gut microbiota composition?
Which specific gut microbiota biomarkers are associated with positive outcomes in Yakult's probiotic and poly-oligo-saccharide intervention study?
What are the potential adverse events of long-term probiotic and poly-oligo-saccharide co-ingestion in healthy populations?
What other prebiotic-probiotic combinations are being studied by Yakult and competitors for microbiota modulation in clinical settings?